One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden from 1998 to 2010: An Observational Study

Stroke

Volumn 48, Issue 8, 2017, Pages 2046-2051

  Bergström, Lisa ^a   Irewall, Anna Lotta ^a   Söderström, Lars ^b   Ögren, Joachim ^a   Laurell, Katarina ^a   Mooe, Thomas ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b ÖSTERSUND HOSPITAL   (Sweden)

Author keywords

atrial fibrillation; diabetes mellitus; epidemiology; myocardial infarction; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; WARFARIN;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RECURRENT DISEASE; REGISTER; REVIEW; RISK REDUCTION; SWEDEN; TREND STUDY; COHORT ANALYSIS; FOLLOW UP; STROKE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; RECURRENCE; REGISTRIES; STROKE; SWEDEN; TIME FACTORS;

EID: 85023767858     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.117.016815     Document Type: Review

References (32)

1. Feigin VL, Mensah GA, Nrrving B, Murray CJ, Rth GA; GBD 2013 Strke Panel Experts Grup. Atlas f the glbal burden f strke (1990-2013): The GBD 2013 study. Neurepidemilgy. 2015;45:230-236. doi: 10.1159/000441106.
2. Mhan KM, Wlfe CD, Rudd AG, Heuschmann PU, Klminsky-Rabas PL, Grieve AP. Risk and cumulative risk f strke recurrence: A systematic review and meta-analysis. Strke. 2011;42:1489-1494. doi: 10.1161/STRKEAHA.110.602615.
3. Tuzé E, Varenne , Chatellier G, Peyrard S, Rthwell PM, Mas JL. Risk f mycardial infarctin and vascular death after transient ischemic attack and ischemic strke: A systematic review and meta-analysis. Strke. 2005;36:2748-2755. doi: 10.1161/01.STR.0000190118.02275.33.
4. Mhan KM, Crichtn SL, Grieve AP, Rudd AG, Wlfe CD, Heuschmann PU. Frequency and predictrs fr the risk f strke recurrence up t 10 years after strke: The Suth Lndn Strke Register. J Neurl Neursurg Psychiatry. 2009;80:1012-1018. doi: 10.1136/jnnp.2008.170456.
5. Petty GW, Brwn RD Jr, Whisnant JP, Sicks JD, 'Falln WM, Wiebers D. Survival and recurrence after first cerebral infarctin: A ppulatinbased study in Rchester, Minnesta, 1975 thrugh 1989. Neurlgy. 1998;50:208-216.
6. Appelrs P, Jnssn F, Åsberg S, Asplund K, Glader EL, Åsberg KH, et al; Riks-Strke Cllabratin. Trends in strke treatment and utcme between 1995 and 2010: Bservatins frm Riks-Strke, the Swedi strke register. Cerebrvasc Dis. 2014;37:22-29. doi: 10.1159/000356346.
7. Burn J, Dennis M, Bamfrd J, Sandercck P, Wade D, Warlw C. Lngterm risk f recurrent strke after a first-ever strke. The xfrdire Cmmunity Strke Prject. Strke. 1994;25:333-337.
8. Dhamn MS, Sciacca RR, Rundek T, Sacc RL, Elkind MS. Recurrent strke and cardiac risks after first ischemic strke: The Nrthern Manhattan Study. Neurlgy. 2006;66:641-646. doi: 10.1212/01.wnl.0000201253.93811.f6.
9. Kang K, Park TH, Kim N, Jang MU, Park SS, Park JM, et al. Recurrent strke, mycardial infarctin, and majr vascular events during the first year after acute ischemic strke: The multicenter prspective bservatinal study abut recurrence and its determinants after acute ischemic strke I. J Strke Cerebrvasc Dis. 2016;25:656-664. doi: 10.1016/j.jstrkecerebrvasdis.2015.11.036.
10. Callaly E, Ni Chrinin D, Hannn N, Marnane M, Akijian L, eehan , et al. Rates, predictrs, and utcmes f early and late recurrence after strke: The Nrth Dublin Ppulatin Strke Study. Strke. 2016;47:244-246. doi: 10.1161/STRKEAHA.115.011248.
11. Pennlert J, Erikssn M, Carlberg B, Wiklund PG. Lng-term risk and predictrs f recurrent strke beynd the acute phase. Strke. 2014;45:1839-1841. doi: 10.1161/STRKEAHA.114.005060.
12. The Riksstrke Cllabratin. Riksstrke the Swedi Strke Register Annual Reprt 2012. http://www.riksstrke.rg/wp-cntent/uplads/2014/2002/Riks-Strkes-Arsrapprt-2012.pdf. Accessed ctber 14, 2015.
13. Hardie K, Jamrzik K, Hankey GJ, Bradhurst RJ, Andersn C. Trends in five-year survival and risk f recurrent strke after first-ever strke in the Perth Cmmunity Strke Study. Cerebrvasc Dis. 2005;19:179-185. doi: 10.1159/000083253.
14. Lewsey J, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, et al. Tempral trends in hspitalisatin fr strke recurrence fllwing incident hspitalisatin fr strke in Sctland. BMC Med. 2010;8:23. doi: 10.1186/1741-7015-8-23.
15. Giang KW, Björck L, Ståhl CH, Nielsen S, Sandström TZ, Jern C, et al. Trends in risk f recurrence after the first ischemic strke in adults yunger than 55 years f age in Sweden. Int J Strke. 2016;11:52-61. doi: 10.1177/1747493015607519.
16. Allen NB, Hlfrd TR, Bracken MB, Gldstein LB, Hward G, Wang Y, et al. Trends in ne-year recurrent ischemic strke amng the elderly in the USA: 1994-2002. Cerebrvasc Dis. 2010;30:525-532. doi: 10.1159/000319028.
17. Lee M, Wu YL, vbiagele B. Trends in incident and recurrent rates f first-ever ischemic strke in Taiwan between 2000 and 2011. J Strke. 2015;18:60-65. doi: 10.5853/js.2015.01326.
18. Santalucia P, Baviera M, Crtesi L, Tettamanti M, Marzna I, Nbili A, et al. Epidemilgic trends in hspitalized ischemic strke frm 2002 t 2010: Results frm a large Italian ppulatin-based study. J Strke Cerebrvasc Dis. 2015;24:1917-1923. doi: 10.1016/j.jstrkecerebrvasdis.2015.05.008.
19. Terént A. Survival after strke and transient ischemic attacks during the 1970s and 1980s. Strke. 1989;20:1320-1326.
20. Kernan WN, vbiagele B, Black HR, Bravata DM, Chimwitz MI, Ezekwitz MD, et al; American Heart Assciatin Strke Cuncil, Cuncil n Cardivascular and Strke Nursing, Cuncil n Clinical Cardilgy, and Cuncil n Peripheral Vascular Disease. Guidelines fr the preventin f strke in patients with strke and transient ischemic attack: A guideline fr healthcare prfessinals frm the American Heart Assciatin/American Strke Assciatin. Strke. 2014;45:2160-2236. doi: 10.1161/STR.0000000000000024.
21. Rthwell PM, Algra A, Amarenc P. Medical treatment in acute and lng-term secndary preventin after transient ischaemic attack and ischaemic strke. Lancet. 2011;377:1681-1692. doi: 10.1016/S0140-6736(11)60516-3.
22. Grup PC. Randmised trial f a perindpril-based bld-pressure-lwering regimen amng 6, 105 individuals with previus strke r transient ischaemic attack. Lancet. 2001;358:1033-1041.
23. Amarenc P, Bgusslavsky J, Callahan A 3rd, Gldstein LB, Hennerici M, Rudlph AE, et al; Strke Preventin by Aggressive Reductin in Chlesterl Levels (SPARCL) Investigatrs. High-dse atrvastatin after strke r transient ischemic attack. N Engl J Med. 2006;355:549-559. doi: 10.1056/NEJMa061894.
24. Antithrmbtic Trialists C. Cllabrative meta-analysis f randmised trials f antiplatelet therapy fr preventin f death, mycardial infarctin, and strke in high risk patients. BMJ. 2002;324:71-86.
25. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrmbtic therapy t prevent strke in patients wh have nnvalvular atrial fibrillatin. Ann Intern Med. 2007;146:857-867.
26. Asplund K, Hulter Åsberg K, Appelrs P, Bjarne D, Erikssn M, Jhanssn A, et al. The Riks-Strke stry: Building a sustainable natinal register fr quality assessment f strke care. Int J Strke. 2011;6:99-108. doi: 10.1111/j.1747-4949.2010.00557.x.
27. Köster M, Asplund K, Jhanssn Å, Stegmayr B. Refinement f Swedi administrative registers t mnitr strke events n the natinal level. Neurepidemilgy. 2013;40:240-246. doi: 10.1159/000345953.
28. Ludvigssn JF, Anderssn E, Ekbm A, Feychting M, Kim JL, Reuterwall C, et al. External review and validatin f the Swedi natinal inpatient register. BMC Public Health. 2011;11:450. doi: 10.1186/1471-2458-11-450.
29. Sacc RL, Benjamin EJ, Brderick JP, Dyken M, Eastn JD, Feinberg WM, et al. American Heart Assciatin Preventin Cnference. IV. Preventin and rehabilitatin f strke. Risk factrs. Strke. 1997;28:1507-1517.
30. Rauti A, Eliassn M, Stegmayr B. Favrable trends in the incidence and utcme in strke in nndiabetic and diabetic subjects: Findings frm the Nrthern Sweden MNICA Strke Registry in 1985 t 2003. Strke. 2008;39:3137-3144. doi: 10.1161/STRKEAHA.107.504100.
31. Klminsky-Rabas PL, Weber M, Gefeller , Neunderfer B, Heuschmann PU. Epidemilgy f ischemic strke subtypes accrding t TAST criteria: Incidence, recurrence, and lng-term survival in ischemic strke subtypes: A ppulatin-based study. Strke. 2001;32:2735-2740.
32. Webb AJ, Rthwell PM. Effect f dse and cmbinatin f antihypertensives n interindividual bld pressure variability: A systematic review. Strke. 2011;42:2860-2865. doi: 10.1161/STRKEAHA.110.611566.